anti sense oligonucleotide; custom made medicine; Europe; personalized medicine; pharmaceutical regulation; RNA
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
DYSTROPHIN;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG QUALITY;
DRUG SAFETY;
DUCHENNE MUSCULAR DYSTROPHY;
EUROPE;
HEALTH CARE ACCESS;
HUMAN;
LICENCE;
PATENT;
PERSONALIZED MEDICINE;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
DRUG INDUSTRY;
LEGISLATION AND JURISPRUDENCE;
SUPPLY AND DISTRIBUTION;
DRUG INDUSTRY;
EUROPE;
LEGISLATION, DRUG;
OLIGONUCLEOTIDES, ANTISENSE;
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. 2012. Available at http://ec.europa.eu/health/files/eudralex/vol-1/dir- 2001-83-consol-2012/dir-2001-83-cons-2012-en.pdf (last accessed July 2013).
Published by the European Commission, DG Research. (last accessed July 2013)
Workshop on personalised medicine. Published by the European Commission, DG Research. 2010. Available at http://ec.europa.eu/research/health/pdf/summary- report-omics-for-personalised-medicine-workshop-en.pdf (last accessed July 2013).
Enabling personalized medicine in Europe: A look at the European Commission's funding activities in the field of personalized medicine research
Draghia-Akli R,. Enabling personalized medicine in Europe: a look at the European Commission's funding activities in the field of personalized medicine research. Pers Med 2012; 9: 152-155.
Challenges posed to the European pharmaceutical regulatory system by highly-personalized medicines
(last accessed October 2013)
Johnston JD, Feldschreiber P,. Challenges posed to the European pharmaceutical regulatory system by highly-personalized medicines. Br J Clin Pharmacol 2014; 77: 421-426. Available at http://onlinelibrary.wiley.com/doi/10. 1111/bcp.12173/pdf (last accessed October 2013).
Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. 2010. Available at http://ec.europa.eu/health/files/eudralex/vol-1/reg-2007-1394-cons-2012-07/ reg-2007-1394-cons-2012-07-en.pdf (last accessed July 2013).
Published by the European Science Foundation. (last accessed July 2013)
Personalised medicine for the European citizen. Published by the European Science Foundation. 2012. Available at http://www.esf.org/uploads/media/ Personalised-Medicine.pdf (last accessed July 2013).
Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. 2007. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri= CONSLEG:1993L0042:20071011:en:PDF (last accessed July 2013).
Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. 1998. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1998:331:0001:0037: EN:PDF (last accessed July 2013).
Published by the Committee for Medicinal Products for Human Use of the European Medicines Agency. (last accessed July 2013)
Guideline on clinical trials in small populations. Published by the Committee for Medicinal Products for Human Use of the European Medicines Agency. 2006. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/ regulation/general/general-content-000366.jsp&mid=WC0b01ac0580032ec4 (last accessed July 2013).
Published by the Committee for Medicinal Products for Human Use of the European Medicines Agency. (last accessed July 2013)
Points to consider on adjustment for baseline covariates. Published by the Committee for Medicinal Products for Human Use of the European Medicines Agency. 2006. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/ regulation/general/general-content-000366.jsp&mid=WC0b01ac0580032ec4 (last accessed July 2013).
Published by the Committee for Medicinal Products for Human Use of the European Medicines Agency. (last accessed July 2013)
Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products. Published by the Committee for Medicinal Products for Human Use of the European Medicines Agency. 2007. Available at http://www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2009/09/WC500002988.pdf (last accessed July 2013).
Published by the Association of the British Pharmaceutical Industry. (last accessed July 2013)
First in human studies: points to consider in study placement, design and conduct. Published by the Association of the British Pharmaceutical Industry. 2011. Available at http://www.abpi.org.uk/our-work/library/guidelines/Pages/ first-human-studies.aspx (last accessed July 2013).
Published by the World Health Organisation. (last accessed July 2013)
Coulter A, Parsons S, Askham J,. Where are the patients in decision-making about their own care? Published by the World Health Organisation 2008. Available at http://www.who.int/management/general/decisionmaking/ WhereArePatientsinDecisionMaking.pdf (last accessed July 2013).
Published by the General Medical Council. (last accessed July 2013)
Consent: patients and doctors making decisions together. Published by the General Medical Council. 2008. Available at http://www.gmc-uk.org/static/ documents/content/GMC-Consent-0513-Revised.pdf (last accessed July 2013).
